Assessing muscle metabolism and insulin resistance in dialysis patients through exercise
Official title: Contribution of Plasma Assays of Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in Chronic Renal Failure Patients Undergoing Hemodialysis.
Run by University Hospital, Montpellier · NCT06360302 · Data updated 2026-11-12
This study is testing how exercise affects muscle metabolism and insulin resistance in dialysis patients compared to those with metabolic syndrome and healthy people to help improve treatment strategies.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 75 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 2 sites (Montpellier and 1 other locations) |
| Status | Recruiting |
| Started | November 18, 2024 |
| Main results expected | November 18, 2026 |
| Study ends | November 18, 2026 |
| Registry record updated | November 26, 2024 |
| Trial ID | NCT06360302 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include postmenopausal women and men aged 40 to 75, specifically those who are non-diabetic CKD dialysis patients, patients with metabolic syndrome, or healthy individuals without chronic diseases.
✕Probably not a fit
Patients with non-stabilized pathologies incompatible with physical exercise or those currently undergoing exercise retraining programs may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares the biochemical and functional responses to exercise in chronic kidney disease (CKD) dialysis patients, patients with metabolic syndrome, and healthy subjects. It aims to identify plasma metabolic intermediates associated with insulin resistance to improve the assessment of muscle oxidative metabolism. By utilizing a metabolomics approach during exercise, the study seeks to create a biological and functional profile that distinguishes between insulin-resistant patients and healthy controls. The findings could enhance understanding of metabolic abnormalities in CKD patients and inform muscle rehabilitation strategies.
Why it matters
Potential benefit: If successful, this study could lead to improved assessment and management of insulin resistance in CKD patients, potentially enhancing their rehabilitation outcomes.
How similar studies have gone: While the approach of using metabolomics in exercise assessments is innovative, similar studies have shown promise in understanding metabolic disorders, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Group 1: Healthy subjects: * Postmenopausal women aged 40 to 75 or men aged 40 to 75 * No chronic disease or treatment * BMI \<30 kg/m², or * Fasting blood glucose \< 1.10 g/dL Group 2: metabolic syndrome patients * Postmenopausal women aged 40 to 75 or men aged 40 to 75 * Metabolic syndrome as defined by the International Diabetes Federation (IDF 2006)5 * BMI \<30 kg/m² and waist circumference \>80 cm for women and \>94 cm for men * Insulin resistance defined by HOMA-IR\>2.4 Group 3: CKD dialysis patients * Non-diabetics * Postmenopausal women aged 40 to 75 and men aged 40 to 75 * BMI \<30 kg/m². * Chronic kidney disease patients on dialysis - stable on HD for more than 3 months Patients and healthy subjects will be matched on age (+/-3 years) and sex Exclusion Criteria: * Non-stabilized pathology incompatible with physical exercise * Ongoing exercise retraining program * Nutritional supplementation in the 4 weeks preceding the study (antioxidants, vitamins, etc.) * Treatment influencing mitochondrial function (metformin, statin, etc.) * Failure to obtain written informed consent after a period of reflection * Subject not affiliated to a social security scheme, or not benefiting from such a scheme. * Person protected by law (under guardianship or curatorship) * Patient deprived of liberty * Diabetic patient * Family dyslipidemia * Participants who have reached the maximum amount of compensation for their participation in research projects * Person under psychiatric care * Person participating in another research project with an exclusion period still in progress. * Mentally handicapped, dementia, illiterate, language barrier with inability to understand study purpose and methodology
Where it's running
-
AIDER Santé Fondation Charles Mion Montpellier, site Lapeyronie
Montpellier, France Recruiting -
Montpellier University Hospital
Montpellier, France Recruiting
Study contacts
- Study coordinator: GRILLET Pierre-Edouard, Pharma D. PhD
- Email: pe-grillet@chu-montpellier.fr
- Phone: 04 67 33 63 81
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy
This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
3D Ultrasound Support for Hemodialysis Cannulation
This study tests whether the EchoMap device can help safely cannulate an arm fistula during hemodialysis for adults.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Low-Calorie Diet in adolescents with Familial Mediterranean Fever and metabolic syndrome
A group of adolescents with both FMF and metabolic syndrome will try a low-calorie diet for 3 months to see if it helps manage metabolic symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.